Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» FDA extends review of Novo Nordisk's Degludec by 3 mths
FDA extends review of Novo Nordisk's Degludec by 3 mths
FDA extends review of Novo Nordisk's Degludec by 3 mths
Submitted by
admin
on June 8, 2012 - 11:49am
Source:
Reuters
News Tags:
FDA
Novo Nordisk
degludec
diabetes
insulin
Headline:
FDA extends review of Novo Nordisk's Degludec by 3 mths
Do Not Allow Advertisers to Use My Personal information
